How to Develop a National Formulary Based on the WHO Model Formulary - A Practical Guide
(2004; 45 pages) View the PDF document
Table of Contents
View the documentAbbreviations
Open this folder and view contents1 INTRODUCTION
Open this folder and view contents2 OVERVIEW OF THE NATIONAL FORMULARY PROCESS
Open this folder and view contents3 DEVELOPING THE PRELIMINARY INFORMATION SECTION
Open this folder and view contents4 DEVELOPMENT OF THERAPEUTIC INFORMATION AND MONOGRAPHS USING THE WHO MODEL FORMULARY
Close this folder5 ADDITIONAL SOURCES OF INFORMATION
View the documentThe evidence-based approach in formulary development
View the documentInformation retrieval
Close this folderTypes of source
View the documentPrimary information sources
View the documentSecondary information sources
View the documentTertiary information sources
View the documentManufacturer’s literature
Open this folder and view contentsSearching for the best evidence
Open this folder and view contentsAccessibility
View the documentCritical appraisal
Open this folder and view contents6 DEVELOPING SPECIFIC INFORMATION SECTIONS
Open this folder and view contents7 PRODUCTION, DISTRIBUTION AND IMPLEMENTATION
Open this folder and view contents8 EVALUATION
Open this folder and view contents9 REVIEW AND UPDATE
View the documentREFERENCES
 

Primary information sources

Primary literature is defined as publications containing original research on drug therapy. It can include published reports of randomized controlled trials, cohort studies, case reports, pharmacological research, toxicological research and other types of evaluation. Journals that publish such information about drug therapies are often available both as printed and electronic publications.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: March 20, 2014